Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Publication in refereed journal


香港中文大学研究人员 ( 现职)

莫树锦教授 (肿瘤学系)

全文

数位物件识别号 (DOI) http://dx.doi.org/10.1056/NEJMoa0810699

引用次数
Web of Sciencehttp://aims.cuhk.edu.hk/converis/portal/Publication/3513WOS source URL

其它资讯

摘要Background: Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in selected patients with non-small-cell lung cancer.

着者Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han BH, Margono B, Ichinose Y, Nishiwaki Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang HY, Duffield EL, Watkins CL, Armour AA, Fukuoka M
期刊名称New England Journal of Medicine
出版年份2009
月份9
日期3
卷号361
期次10
出版社Massachusetts Medical Society
页次947 - 957
国际标準期刊号0028-4793
电子国际标準期刊号1533-4406
语言英式英语

Web of Science 学科类别General & Internal Medicine; Medicine, General & Internal; MEDICINE, GENERAL & INTERNAL